Wisnewski Nancy

Avg. Two Year Performance

No purchase track record
6% Avg. Sale Return
3% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(< 1%)(5%)(5%)8%6%
Sale Success Rate4 of 94 of 93 of 92 of 94 of 9

Heska Corp.

Drugs » Biotechnology

Chief Operating Officer:

Holdings: 81.08K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--